Abramson Cancer Center of the University of Pennsylvania

Abramson Cancer Center of the University of Pennsylvania

“Best Hospitals” cancer-care rank: 13

“Best Hospitals” cancer-care score: 65.9/100

Founded: 1973

Beds:  782

Clinicians/researchers: 400




Research focus: 

Translational research, developmental therapeutics, immunobiology and clinical trials.


Clinic at-a-glance:

Designated a comprehensive cancer center by the National Cancer Institute, Abramson Cancer Center is a recognized leader in cancer research, patient care and education. The institution is dedicated to innovative and compassionate cancer care; it provides a spectrum of treatment and follow-up care, including biologic therapy/immunotherapy, chemotherapy, hormone therapy, integrative medicine and wellness, photodynamic therapy, proton therapy, radiation treatment, surgery, targeted therapy, and vaccine therapy. Notably, the organization Hosts for Hospitals arranges to temporarily lodge families, spouses and friends of patients (outpatients, too) at no cost in the private homes of volunteers near Abramson. The center is credited with many research breakthroughs, including discovering the first evidence that abnormal chromosomes can cause cancer and finding a way to employ antibodies as weapons against cancer. Abramson offers patients opportunities to participate in clinical trials; the institution has nearly 200 of them currently active.